The convalescent sera option for containing COVID-19

被引：624
作者：
Casadevall, Arturo [1 ]
Pirofski, Liise-Anne [2 ]
机构：
[1] Johns Hopkins Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA
[2] Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10467 USA
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2020年 / 130卷 / 04期
关键词：
EBOLA-VIRUS DISEASE; INFLUENZA PNEUMONIA; ANTIBODY; PLASMA; INFECTION; THERAPY; PROTECTION; IMMUNITY; MEASLES; BLOOD;
D O I：
10.1172/JCI138003
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：1545 / 1548
页数：4
相关论文
共 33 条
[1]   Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia [J].
Arabi, Yaseen M. ;
Hajeer, Ali H. ;
Luke, Thomas ;
Raviprakash, Kanakatte ;
Balkhy, Hanan ;
Johani, Sameera ;
Al-Dawood, Abdulaziz ;
Al-Qahtani, Saad ;
Al-Omari, Awad ;
Al-Hameed, Fahad ;
Hayden, Frederick G. ;
Fowler, Robert ;
Bouchama, Abderrezak ;
Shindo, Nahoko ;
Al-Khairy, Khalid ;
Carson, Gail ;
Taha, Yusri ;
Sadat, Musharaf ;
Alahmadi, Mashail .
EMERGING INFECTIOUS DISEASES, 2016, 22 (09) :1554-1561
[2]   Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study [J].
Beigel, John H. ;
Voell, Jocelyn ;
Kumar, Parag ;
Raviprakash, Kanakatte ;
Wu, Hua ;
Jiao, Jin-An ;
Sullivan, Eddie ;
Luke, Thomas ;
Davey, Richard T., Jr. .
LANCET INFECTIOUS DISEASES, 2018, 18 (04) :410-418
[3]   Passive antibody therapy for infectious diseases [J].
Casadevall, A ;
Dadachova, E ;
Pirofski, L .
NATURE REVIEWS MICROBIOLOGY, 2004, 2 (09) :695-703
[4]   Antibody-mediated regulation of cellular immunity and the inflammatory response [J].
Casadevall, A ;
Pirofski, LA .
TRENDS IN IMMUNOLOGY, 2003, 24 (09) :474-478
[5]   RETURN TO THE PAST - THE CASE FOR ANTIBODY-BASED THERAPIES IN INFECTIOUS-DISEASES [J].
CASADEVALL, A ;
SCHARFF, MD .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (01) :150-161
[6]   SERUM THERAPY REVISITED - ANIMAL-MODELS OF INFECTION AND DEVELOPMENT OF PASSIVE ANTIBODY THERAPY [J].
CASADEVALL, A ;
SCHARFF, MD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (08) :1695-1702
[7]   Use of convalescent plasma therapy in SARS patients in Hong Kong [J].
Cheng, Y ;
Wong, R ;
Soo, YOY ;
Wong, WS ;
Lee, CK ;
Ng, MHL ;
Chan, P ;
Wong, KC ;
Leung, CB ;
Cheng, G .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (01) :44-46
[8]   Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines [J].
Crowe, JE ;
Firestone, CY ;
Murphy, BR .
JOURNAL OF IMMUNOLOGY, 2001, 167 (07) :3910-3918
[9]   Transfusion-related acute lung injury in the critically III: Prospective nested case-control study [J].
Gajic, Ognjen ;
Rana, Rimki ;
Winters, Jeffrey L. ;
Yilmaz, Murat ;
Mendez, Lose L. ;
Rickman, Otis B. ;
O'Byrne, Megan M. ;
Evenson, Laura K. ;
Malinchoc, Michael ;
DeGoey, Steven R. ;
Afessa, Bekele ;
Hubmayr, Rolf D. ;
Moore, S. Breanndan .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (09) :886-891
[10]   Use of Convalescent Measles Serum to Control Measles in a Preparatory School [J].
Gallagher, J. Roswell .
AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1935, 25 (05) :595-598
1234